| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |